Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 654-656 , December 2009

Incidental CNS involvement of testicular germ cell cancer: a growing trend?

Received 27 March 2009 ,Accepted 26 April 2009.

References 

  1. Furtado CD, Aguirre DA, Sirlin CB, et al. Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology. 2005;237:385–394
  2. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594–603.
  3. Bokemeyer C, Nowak P, Haupt A, et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol. 1997;15:1449–1454
  4. Higi M, Scheulen ME, Schmidt CG, Seeber S. [Brain metastases in malignant testicular teratomas]. Onkologie. 1981;4:84–86
  5. Raina V, Singh SP, Kamble N, et al. Brain metastasis as the site of relapse in germ cell tumor of testis. Cancer. 1993;72:2182–2185
  6. Oechsle K, Kollmannsberger C, Honecker F, et al. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy. Eur J Cancer. 2008;44:1663–1669
  7. Einhorn LH, Williams SD, Chamness A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357:340–348
  8. Spears WT, Morphis JG, Lester SG, et al. Brain metastases and testicular tumors: long-term survival. Int J Radiat Oncol Biol Phys. 1992;22:17–22
  9. Fossa SD, Bokemeyer C, Gerl A, et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer. 1999;85:988–997
  10. Salvati M, Piccirilli M, Raco A, et al. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment. Neurosurg Rev. 2006;29:130–137
  11. Panel NTC. NCCN Practice Guidelines in Oncology – v.2.2008: Testicular Cancer. In: 2nd ed., NCCN 2008.
  12. Rustin GJ, Newlands ES, Bagshawe KD, et al. Successful management of metastatic and primary germ cell tumors in the brain. Cancer. 1986;57:2108–2113
  13. Azar JM, Schneider BP, Einhorn LH. Is the blood–brain barrier relevant in metastatic germ cell tumor?. Int J Radiat Oncol Biol Phys. 2007;69:163–166
  14. de Wit R, van den Bent M, Kirkels W. The management of cerebral metastasis from germ cell cancer; walking the tightrope. Eur J Cancer. 2008;44:1622–1624
  15. Raj S, Parkinson C, Williams M, Mazhar D. Management of brain metastases from germ cell tumors: do we know what we are doing?. Future Oncol. 2008;4:1–4
  16. Doyle DM, Einhorn LH. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases. Int J Radiat Oncol Biol Phys. 2008;70:1361–1364
  17. Baudendistel KT, Heverhagen JT, Knopp MV. Clinical MR at 3 Tesla: current status. Radiologe. 2004;44:11–18
  18. Sanchez de Cos J, Sojo Gonzalez MA, Montero MV, et al. Non-small cell lung cancer and silent brain metastasis Survival and prognostic factors. Lung Cancer. 2008;
  19. Oh Y, Stewart DJ. Systemic therapy for lung cancer brain metastases: a rationale for clinical trials. Oncology (Williston Park). 2008;22:168–178[discussion 178, 183, 188 passim]
  20. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751

PII: S0167-8140(09)00199-6

doi: 10.1016/j.radonc.2009.04.024

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 654-656 , December 2009

Article Tools

* Image Usage & Resolution